Medgenics, the developer of technology for the sustained production and delivery of therapeutic proteins in patients using their own tissue, reported that its wholly owned subsidiary Medgenics Medical Israel was awarded a government grant of up to NIS 8.1 million (approximately $2.2 million) from the Office of the Chief Scientist in Israel. The grant will be used to cover R&D expenses to support further clinical development of the company’s proprietary tissue-based Biopump platform technology. Medgenics holds offices in San Francisco, California and Misgav, Israel.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts

$10M For Startup That Cuts Hotels’ Costs
March 28, 2023

Researchers Test High-Capacity Titanium-Air Battery
March 28, 2023

Israel Exports Startup Expertise to Uruguay
March 28, 2023

New Micro-Robot Is The Size Of A Human Cell
March 27, 2023
Facebook comments